Insight Molecular Diagnostics (IMDX) Total Debt Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Total Debt Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 22.57% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 48.73% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | -20.41% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | -4.01% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 3.29% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -72.17% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -0.07% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -3.29% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | -0.37% |
| 10 | Insight Molecular Diagnostics | 172.94 Mn | 144.01 Mn | 15,000.00 | -63.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.28% |
| Dec 31, 2025 | 87.72% |
| Sep 30, 2025 | 71.99% |
| Dec 31, 2024 | -90.15% |
| Sep 30, 2024 | 463.30% |
| Dec 31, 2023 | 2,022.94% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -81.01% |
| Mar 31, 2023 | -88.47% |
| Dec 31, 2022 | -92.15% |
| Sep 30, 2022 | -95.48% |
| Jun 30, 2022 | -95.32% |
| Mar 31, 2022 | -73.31% |
| Dec 31, 2021 | -64.39% |
| Sep 30, 2021 | -41.49% |
| Jun 30, 2021 | 199.10% |
| Mar 31, 2021 | 15.53% |
| Dec 31, 2020 | 103.98% |
| Sep 30, 2020 | 615.08% |
| Jun 30, 2020 | 433.68% |